secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2026-10-02T11:31:27+00:00
Accession:  0001104659-26-113043
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

BNB Plus pivots from BNB Chain treasury to blockchain/AI infrastructure; weighs GlobalStake expansion, LineaRx options
--------------------------------------------------------------------------------

- BNBX is abandoning its passive digital-asset treasury model focused on the BNB Chain to become an operating company deploying blockchain and agentic AI infrastructure for institutions.
- Company is evaluating an expansion of its relationship with GlobalStake Infrastructure LLC, which has been leading BNBX's strategic review; Chairman Richard Shorten founded GlobalStake.
- BNBX will assess options to strengthen subsidiary LineaRx, Inc. (LRx), whose enzymatic DNA manufacturing platform supplies DNA for mRNA and other genetic medicines, to realize value for stockholders.
- CEO Clay Shorrock, who is also LRx President, cited the industry's recent Phase 3 success of a personalized mRNA cancer therapy as evidence of demand for high-quality DNA.
- No deal values, financial terms or timelines were disclosed; BNBX said it expects to remain an active participant in the BNB Chain ecosystem.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465926113043/0001104659-26-113043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465926113043/tm2626879d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-113043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer